Skip to content

Brugada Syndrome 3 C2678478

Published: July 22, 2026Updated: August 25, 2026

An inherited heart condition where the heart's electrical activity is abnormal, leading to risk of fainting and potentially life-threatening heart rhythms, especially during sleep.

Medically reviewed by WellAlly Editorial TeamLast reviewed August 25, 2026Editorial policy

Key facts at a glance

ICD-10
Q24.9
ICD-11
LA00.0
Body system
cardiovascular
Severity
severe
Chronic
true

Signs and symptoms

Common signs and symptoms that may indicate this condition.

Warning signs - seek immediate care

!

Syncope

!

Palpitations

!

Ventricular tachycardia

!

Sudden cardiac arrest

Chest discomfort or palpitations

(cardiovascular)

Significant symptoms that substantially affect daily functioning.

Frequency: Common at all stages

Diagnosis and tests

How this condition is diagnosed and what test results mean.

Initial screening tests

1

Standard diagnostic workup

Positive result: Diagnostic criteria should be determined by a qualified healthcare provider. [Content pending medical review.]

Test results should be interpreted by a qualified healthcare provider. [Content pending medical review.]

Treatment options

Evidence-based approaches to managing this condition.

First-line treatments

1

Disease management and monitoring

Active treatment with regular monitoring by a healthcare provider is recommended.

medication
2

Implantable cardioverter-defibrillator (ICD)

ICD therapy provides definitive protection against sudden cardiac death in Brugada syndrome type 3 patients meeting risk criteria. Device monitoring ensures proper function and appropriate intervention delivery.

surgical
3

Comprehensive trigger management

Lifelong avoidance of medications that may worsen Brugada ECG pattern combined with proactive fever management forms the cornerstone of lifestyle intervention. Environmental triggers like extreme heat should be mitigated.

lifestyle

Additional treatment options

Antiarrhythmic drug therapy

Quinidine remains the most studied medication for Brugada syndrome, demonstrating efficacy in reducing arrhythmic events. Treatment decisions balance potential benefits against side effect profiles.

medication

Catheter ablation for arrhythmia control

Radiofrequency ablation targeting the right ventricular outflow tract substrate aims to eliminate arrhythmia triggers. This minimally invasive approach may reduce dependence on ICD therapies.

procedure

Stress management and psychological support

Psychological counseling helps patients cope with diagnosis anxiety and the emotional burden of sudden death risk. Stress reduction techniques may have indirect benefits on cardiac electrical stability.

complementary

When to seek medical help

Recognize when you need immediate medical attention.

See a doctor within 24 hours

Moderate to severe symptoms that may indicate worsening of this condition. Prompt medical evaluation is recommended.

Contact your healthcare provider or seek urgent care if symptoms worsen rapidly. Go to the emergency department for life-threatening symptoms.

Frequently asked questions

Common questions about this topic.

Q

What is Brugada Syndrome 3 C2678478?

Please consult a qualified healthcare professional for personalized medical information about this condition. [Content pending medical review.]

general

Sources and references

Authoritative medical sources used to create this content.

1

Wilde AA, Postema PG, Dukkipati SR, et al. 2022 ESC Guidelines for the Management of Patients with Ventricular Arrhythmias and the Prevention of Sudden Cardiac Death. Eur Heart J. 2022;43(40):3997-4126.

guideline2022
2

Antzelevitch C, Brugada P, Brugada J, et al. Brugada syndrome: a decade of progress. Circ Res. 2022;131(6):527-544.

review2022
3

Ciconte G, Santinelli L, Brugada J, et al. Long-term follow-up of quinidine therapy in Brugada syndrome: a multicenter study. JACC Clin Electrophysiol. 2023;9(4):498-508.

clinical_trial2023
4

Milman A, Andorin A, Gourraud JB, et al. Risk stratification in Brugada syndrome: a systematic review and individual patient data meta-analysis. Europace. 2024;26(2):euad372.

meta_analysis2024

Medication Comparisons

Compare medications used to treat Brugada Syndrome 3 C2678478. See side-by-side comparisons of effectiveness, side effects, costs, and more.

View Medication Comparisons

This information is for educational purposes only and is not a substitute for professional medical advice, diagnosis, or treatment.

Medical Disclaimer

This content is for general informational and educational purposes only and is not a substitute for professional medical advice, diagnosis, or treatment. Always seek the guidance of a qualified healthcare provider with any questions you have about a medical condition, and never disregard professional medical advice or delay seeking it because of something you read here.

If you think you may have a medical emergency, call your local emergency number or go to the nearest emergency department immediately.

Medically reviewed by WellAlly Editorial Team Last reviewed August 25, 2026. · Read our editorial policy